Hyperphosphatemia is not significantly associated with increased all-cause mortality in Korean hemodialysis patients

DOI QR Code

Wakasugi, Minako (Division of Comprehensive Geriatrics in Community, Niigata University Graduate School of Medical and Dental Sciences) ;
Sakaguchi, Yusuke (Department of Inter-Organ Communication Research in Kidney Disease, Osaka University Graduate School of Medicine)

Kim Y, Yoo KD, Kim HJ, et al. Association of serum mineral parameters with mortality in hemodialysis patients: data from the Korean end-stage renal disease registry. Kidney Res Clin Pract 37:266-276, 2018 https://doi.org/10.23876/j.krcp.2018.37.3.266
Wakasugi M, Kazama JJ, Wada A, Hamano T, Masakane I, Narita I. Functional impairment attenuates the association between high serum phosphate and mortality in dialysis patients: a nationwide cohort study. Nephrol Dial Transplant 2018 Aug 13. doi: 10.1093/ndt/gfy253. [Epub ahead of print]
Sakaguchi Y, Fujii N, Shoji T, et al; Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy. Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study. PLoS One 9:e116273, 2014 https://doi.org/10.1371/journal.pone.0116273
Lee S, Ryu JH, Kim SJ, Ryu DR, Kang DH, Choi KB. The relationship between magnesium and endothelial function in end-stage renal disease patients on hemodialysis. Yonsei Med J 57:1446-1453, 2016 https://doi.org/10.3349/ymj.2016.57.6.1446
Sakaguchi Y, Hamano T, Isaka Y. Effects of magnesium on the phosphate toxicity in chronic kidney disease: time for intervention studies. Nutrients 9:112, 2017 https://doi.org/10.3390/nu9020112